Filana Therapeutics, Inc. FLNA
Set alert
0.62 USD -0.04 -5.47%
At close · Oct 30
0.64 +0.02 +2.51%
After hours · Oct 30, 4:58 PM ET
0.62 Day range 0.6585
0.61 52-week range 3.39
- YTD
- -68.59%
- 1 year
- -81.04%
- Open
- 0.6585
- Prev close
- 0.658
- Mkt cap
- 30.05M
- Vol
- 215.57K
- Avg vol
- 2.02M
- EPS
- -0.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.62
- High
- 0.6585
1D chart
Signals (40)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | 4:00 PM | 2 days ago |
| SMA: Bullish | 4:00 PM | 2 days ago |
| SMA: Bearish | 3:59 PM | 2 days ago |
| SMA: Bearish | 3:59 PM | 2 days ago |
| SMA: Bullish | 3:53 PM | 2 days ago |
| SMA: Bullish | 3:53 PM | 2 days ago |
| SMA: Bearish | 3:51 PM | 2 days ago |
| SMA: Bearish | 3:51 PM | 2 days ago |
| SMA: Bullish | 3:50 PM | 2 days ago |
| SMA: Bullish | 3:50 PM | 2 days ago |
| RSI: Overbought | 3:50 PM | 2 days ago |
| MACD: Buy Signal | 3:45 PM | 2 days ago |
| MACD: Sell Signal | 3:26 PM | 2 days ago |
| SMA: Bearish | 3:23 PM | 2 days ago |
| SMA: Bearish | 3:23 PM | 2 days ago |
| SMA: Bullish | 3:18 PM | 2 days ago |
| SMA: Bullish | 3:18 PM | 2 days ago |
| SMA: Bearish | 3:15 PM | 2 days ago |
| SMA: Bullish | 3:14 PM | 2 days ago |
| SMA: Bearish | 3:07 PM | 2 days ago |
| SMA: Bullish | 3:04 PM | 2 days ago |
| SMA: Bearish | 3:01 PM | 2 days ago |
| SMA: Bearish | 3:01 PM | 2 days ago |
| SMA: Bullish | 2:59 PM | 2 days ago |
| SMA: Bullish | 2:59 PM | 2 days ago |
| SMA: Bearish | 2:31 PM | 2 days ago |
| SMA: Bullish | 2:29 PM | 2 days ago |
| MACD: Buy Signal | 2:05 PM | 2 days ago |
| MACD: Sell Signal | 2:04 PM | 2 days ago |
| MACD: Buy Signal | 1:25 PM | 2 days ago |
| MACD: Sell Signal | 1:18 PM | 2 days ago |
| SMA: Bearish | 1:15 PM | 2 days ago |
| SMA: Bullish | 1:08 PM | 2 days ago |
| SMA: Bearish | 1:06 PM | 2 days ago |
| SMA: Bullish | 1:00 PM | 2 days ago |
| MACD: Buy Signal | 1:00 PM | 2 days ago |
| MACD: Sell Signal | 12:34 PM | 2 days ago |
| SMA: Bearish | 11:52 AM | 2 days ago |
| SMA: Bullish | 11:46 AM | 2 days ago |
| RSI: Oversold | 10:29 AM | 2 days ago |
Financials — quick view
FLNA Revenue — quarterly 0
FLNA Net income — quarterly -8.60M
FLNA EPS — quarterly -0.18
News
- Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes
- Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
- Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
- Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
- FDA Lifts Clinical Hold Form Filana Therapeutics' Investigational New Drug Application To Initiate Planned Phase 2a Trial In Participants With Tuberous Sclerosis Complex-Related Epilepsy
Your note
Sign in to keep a note on FLNA — it syncs with the Stock Master app.